Home DE ES FR


Advanced Search

Our On-Line PhDs

Submit a Thesis
My Account Register Help

About
Fields
Mathematics and Applications
Information and Communication Sciences and Technologies
Physics, Optics
Materials Science, Mechanics and Mechanical Engineering
Fluid Mechanics and Energy
Chemistry, Physical Chemistry and Chemical Engineering
Life Sciences and Engineering
Earth Sciences and Environmental Engineering
Sciences of Economy, Management and Society
Synthesis and biological assessment of organometallic tamoxifen derivatives for the diagnosis and the treatment of breast cancer

Nguyen, Anh (2007) Synthesis and biological assessment of organometallic tamoxifen derivatives for the diagnosis and the treatment of breast cancer. PhD thesis Chimie BioOrganométallique, ENSCP p.165.

Full text available as:

- these.pdf ( 3123 Kb )
Licence: Copyright

Abstract

Since breast cancer is still a leading cause of cancer death among women, improvements in diagnosis and therapy for this disease have to be explored more than ever. Using robust organometallic compounds and targeting them to the estrogen receptor, enables us to broaden their applications by choosing the appropriate metal.

For the first time were described compounds where the key amino side-chain of hydroxytamoxifen has been replaced by a lipophilic and stable organometallic entity, a ferrocenyl moiety. This amino side-chain was deemed essential for the anti-estrogenic activity. Additionally, the amino side-chain of the ferrocifens was also substituted by a carboxylate group. Various parameters were tested to optimise the biological activity of the ferrocenyl compounds.

The versatility of some of the ferrocenyl derivatives synthetized lie in their ability to be both a potential drug and a stable precursor for the synthesis of radiopharmaceuticals. The compounds were succesfully labeled by a double ligand exchange reaction with Re and Tc, which proved to be chemioselective. These high affinity organometallic compounds could be potential site-specific radiotherapeutic (188Re derivatives), or radioimaging (99mTc derivatives) agents.

Finally, in order to improve their bioavailability, two most interesting organometallic tamoxifen-like compounds were incorporated in two types of stealth nanoparticles: nanospheres and nanocapsules. An efficient anticancer organometallic triphenylethylene-loaded nanosystems have been developed for the first time. Their small size and delayed drug release, combined with their enhanced apoptotic potential, are compatible with an increased persistence in the blood and a promising antitumour activity.

Item Type:PhD Thesis (PhD)
Thesis Supervisor:Jaouen, Gérard
Date:30 October 2007
Board of examiners:Poli, Giovanni and Alberto, Roger and Metzler-nolte, Nils and Renoir, Jack-Michel and Top, Siden
Ecole Doctorale:ED 406 CHIMIE MOLECULAIRE
Discipline:Chimie BioOrganométallique
Collection (Fonds):ENSCP
Institution:ENSCP
Subjects:6. Chemistry, Physical Chemistry and Chemical Engineering
Uncontrolled Keywords:Ferrocène, Serm, Hydroxytamoxifène, Cancer du sein, Chimie bioorganométallique, Radiopharmaceutiques, Technétium, Rhénium, Nanoparticules, Encapsulation, Ferrocene, Serm, Hydroxytamoxifen, Breast cancer, Bioorganometallic chemistry, Radiopharmaceuticals, Technetium, Rhenium, Nanoparticles, Encapsulation
ID Code:3191
Deposited By:Anh NGUYEN
Deposited On:17 December 2007

Statistiques de consultation

Repository Staff Only: edit this item

© ParisTech 2007 - Réalisé par RILK.com - Graphisme par Winch Communication